Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase1, Phase2, Recruiting
Active & Responsive
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
for
Metastatic Solid Tumors
Location: Nashville TN, Houston TX, Irving TX, San Antonio TX,
Sponsor: Erasca, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07021898
Phase1, Recruiting
Active & Responsive
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumors
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Erasca, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06983743
Phase1, Recruiting
Active & Responsive
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Nashville TN, Houston TX,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612176
Phase1, Recruiting
Active & Responsive
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Dothan AL, Grand Rapids MI, Omaha NE
Sponsor: Radiopharm Theranostics, Ltd
Sex: All
Age: 18+
Code: NCT07189871
Phase1, Phase2, Recruiting
Interested in new advanced solid tumor trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
for
Solid Tumors
Location: Baltimore MD
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07492680
Phase2, Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Dallas TX, Scottsdale AZ, Portland OR, El Segundo CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
Solid Tumor Malignancies
Location: New Haven CT, Fairfax VA, Jacksonville FL, Sarasota FL,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06994806
Phase1, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Phase2, Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Location: Boston MA, New Haven CT, Mineola NY, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03816345
Phase1, Recruiting
New
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, San Antonio TX, Duarte CA
Sponsor: VelaVigo Bio Inc
Sex: All
Age: 18+
Code: NCT07700160
Phase1, Phase2, Recruiting
New
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
for
Selected Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Glen Burnie MD
Sponsor: SK Life Science, Inc.
Sex: All
Age: 18+
Code: NCT07812805
Phase1, Recruiting
New
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New York NY, Houston TX
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT07408258
Phase1, Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT06241456
Phase1, Recruiting
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Durham NC,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase1, Phase2, Recruiting
64Cu-GRIP B in Patients With Advanced Malignancies
for
Prostate Cancer, Renal Cancer, Urethral Cancer,
Location: San Francisco CA
Sponsor: Rahul Aggarwal
Sex: All
Age: 18+
Code: NCT05888532
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: New York NY, Jacksonville FL, Cleveland OH,
Sponsor: GI Innovation, Inc.
Sex: All
Age: 18+
Code: NCT05824975
Phase1, Phase2, Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: New Haven CT, New York NY, The Bronx NY,
Sponsor: SillaJen, Inc.
Sex: All
Age: 18+
Code: NCT05768932
Phase1, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase1, Phase2, Recruiting
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors